Tag Archives: Bowel

Diabetes Medicines In DPP-4 Inhibitor Class Might Not Increase Risk Of Inflammatory Bowel Disease (IBD) 

But New Medical Study Finds That Januvia, Onglyza, Other Drugs In Class Significantly Increase Risk Of Crohn's Disease (CD)   (Posted by Tom Lamb at DrugInjuryWatch.com)   Back in March 2018 we wrote this report, "Januvia, Onglyza, And Certain Other … Continue reading

Posted in Health Law | Tagged , , , , , , , , , , , | Leave a comment

Januvia, Onglyza, And Certain Other Diabetes Drugs Linked To Inflammatory Bowel Disease (IBD)

New Study Finds Overall 75% Increase In Risk Of IBD, And Association Peaked Between 3 And 4 Years Of Use   (Posted by Tom Lamb at DrugInjuryWatch.com)   According to an observational study published on March 21, 2018 by The … Continue reading

Posted in Health Law | Tagged , , , , , , , , | Leave a comment

$1.65 Million Mediation Settlement Reached in Late Diagnosis and Treatment of Bowel Perforations

In a confidential report of this case, Doe, age 55, underwent a laparoscopic cholecystectomy performed by a surgeon and partner. During the procedure, the surgeon was concerned that one of the trocars used could have perforated the patient’s small bowel. … Continue reading

Posted in Medical malpractice law | Tagged , , , , , , , , , | Leave a comment